OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Olema Oncology to Participate in Upcoming Investor Conferences
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 4 Olema Pharmaceuticals, For: Nov 15 Filed by: Kovacs Shane William Charles
Form SC 13G/A Olema Pharmaceuticals, Filed by: Paradigm Biocapital Advisors LP
Form SC 13G/A Olema Pharmaceuticals, Filed by: Deep Track Capital, LP
Form 10-Q Olema Pharmaceuticals, For: Sep 30
Form 8-K Olema Pharmaceuticals, For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.